The 7 analysts offering 12-month price forecasts for Gritstone Oncology Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 16.00. The median estimate represents a +266.30% increase from the last price of 5.46.
The current consensus among 8 polled investment analysts is to Buy stock in Gritstone Oncology Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.73
Reporting Date May 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.